Issues surrounding trials for rare cancers

Princess Dina Mired's work with the King Hussein Cancer Foundation

Research reproducibility and scientific ecosystems

The importance of significant genetic variations between breast cancers

Results of 5 year phase III randomised trial treating localised prostate cancer

ECC 2015: Editor's highlights

Review of data and expert opinion from IMW 2015: Asian perspective

Diagnosis while pregnant should not lead to treatment delay or pregnancy termination

DDFMISO trial confirms significant negative prognostic value of tumour hypoxia

'Survivor passport' for survivors of childhood leukaemia

Progression of childhood cancers in Europe

Expanding access to crizotinib using a biomarker-driven approach